Sativex® is a cannabinoid medicine for the treatment of spasticity

Stuart SchlossmanAlternative therapies and devices for Multiple Sclerosis (MS)

Sativex® is a cannabinoid medicine for the treatment of spasticity due to multiple sclerosis which is also in development in cancer pain and neuropathic pain of various origins..


.Sativex® has now been launched in 11 countries (including the UK, Spain, Italy and Germany) and approved in a further 13 (Click here to see map)

For more information, including: UK Information for Physicians and Patients

.Sativex Banner
.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews